{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "55505-230",
      "generic_name": "Acetaminophen, Dextromethorphan Hydrobromide, and Guaifenesin",
      "labeler_name": "KRAMER LABORATORIES",
      "brand_name": "SAFETUSSIN MAX STRENGTH MS Cough, Cold and Flu",
      "brand_name_suffix": "Cough, Cold and Flu",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "325 mg/1"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "10 mg/1"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "55505-230-24",
          "description": "24 TABLET in 1 CARTON (55505-230-24)",
          "marketing_start_date": "20240517",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "KRAMER LABORATORIES"
        ],
        "rxcui": [
          "2684921"
        ],
        "spl_set_id": [
          "920bde5f-4079-45de-aa59-24b00e50cb56"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0053076000085"
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "362O9ITL9D",
          "9D2RTI9KYH",
          "495W7451VQ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET",
      "spl_id": "3dbd264d-5108-4b29-8881-728cea879dd7",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20240517",
      "product_id": "55505-230_3dbd264d-5108-4b29-8881-728cea879dd7",
      "application_number": "M012",
      "brand_name_base": "SAFETUSSIN MAX STRENGTH MS",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}